In this study, we demonstrated that the loss of miR-4454 expression in a resistant clone prominently promoted tumor initiation, metastatic outgrowth, and resistant status through the GNL3L/NFκB signaling axis against anticancer drug therapy. This evidence concerns the gene NFKB1 and neoplasm.